MicroRNA editing patterns in Huntington's disease

Sci Rep. 2022 Feb 24;12(1):3173. doi: 10.1038/s41598-022-06970-6.

Abstract

Huntington's disease (HD) is a neurodegenerative disease. MicroRNAs (miRNAs) are small non-coding RNAs that mediate post-transcriptional regulation of target genes. Although miRNAs are extensively edited in human brains, the editome of miRNAs in brains of HD patients is largely unknown. By analyzing the small RNA sequencing profiles of brain tissues of 28 HD patients and 83 normal controls, 1182 miRNA editing sites with significant editing levels were identified. In addition to 27 A-to-I editing sites, we identified 3 conserved C-to-U editing sites in miRNAs of HD patients. 30 SNPs in the miRNAs of HD patients were also identified. Furthermore, 129 miRNA editing events demonstrated significantly different editing levels in prefrontal cortex samples of HD patients (HD-PC) when compared to those of healthy controls. We found that hsa-mir-10b-5p was edited to have an additional cytosine at 5'-end in HD-PC, and the edited hsa-mir-10b repressed GTPBP10 that was often downregulated in HD. The down-regulation of GTPBP10 might contribute to the progression of HD by causing gradual loss of function of mitochondrial. These results provide the first endeavor to characterize the miRNA editing events in HD and their potential functions.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Brain / metabolism
  • Disease Progression
  • Gene Expression Regulation
  • Humans
  • Huntington Disease / genetics*
  • Huntington Disease / metabolism*
  • MicroRNAs / metabolism*
  • Monomeric GTP-Binding Proteins / metabolism*
  • Polymorphism, Single Nucleotide
  • Prefrontal Cortex / metabolism*
  • Sequence Analysis, RNA
  • Transcriptome

Substances

  • MIRN10 microRNA, human
  • MicroRNAs
  • GTPBP10 protein, human
  • Monomeric GTP-Binding Proteins